Nutritional Assessment in Gastrointestinal Tumors: News from the 2020 ASCO and ESMO World GI Meetings
Abstract
1. Introduction
2. Results
2.1. Colorectal Cancer
2.2. Gastric Cancer
2.3. Esophageal Cancer
2.4. Pancreatic Cancer
3. Discussion
4. Materials and Methods
Funding
Conflicts of Interest
References
- Garla, P.; Waitzberg, D.L.; Tesser, A. Nutritional Therapy in Gastrointestinal Cancers. Gastroenterol. Clin. N. Am. 2018, 47, 231–242. [Google Scholar] [CrossRef] [PubMed]
- Arnold, M.; Abnet, C.C.; Neale, R.E.; Vignat, J.; Giovannucci, E.L.; McGlynn, K.A.; Bray, F. Global Burden of 5 Major Types of Gastrointestinal Cancer. Gastroenterology 2020, 159, 335–349. [Google Scholar] [CrossRef] [PubMed]
- Schwingshackl, L.; Hoffmann, G. Adherence to Mediterranean diet and risk of cancer: An updated systematic review and meta-analysis of observational studies. Cancer Med. 2015, 4, 1933–1947. [Google Scholar] [CrossRef] [PubMed]
- Ni, J.; Zhang, L. Cancer Cachexia: Definition, Staging, and Emerging Treatments. Cancer Manag. Res. 2020, 12, 5597–5605. [Google Scholar] [CrossRef]
- Zhang, L.; Lu, Y.; Fang, Y. Nutritional status and related factors of patients with advanced gastrointestinal cancer. Br. J. Nutr. 2014, 111, 1239–1244. [Google Scholar] [CrossRef]
- Onodera, T.; Goseki, N.; Kosaki, G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 1984, 85, 1001–1005. [Google Scholar]
- Eo, W.K.; Chang, H.J.; Suh, J.; Ahn, J.; Shin, J.; Hur, J.Y.; Kim, G.Y.; Lee, S.; Park, S.; Lee, S. The Prognostic Nutritional Index Predicts Survival and Identifies Aggressiveness of Gastric Cancer. Nutr. Cancer 2015, 67, 1260–1267. [Google Scholar] [CrossRef]
- Nozoe, T.; Kohno, M.; Iguchi, T.; Mori, E.; Maeda, T.; Matsukuma, A.; Ezaki, T. The prognostic nutritional index can be a prognostic indicator in colorectal carcinoma. Surg. Today 2012, 42, 532–535. [Google Scholar] [CrossRef]
- Costa, I.; Reis, J.; Valente, A.; Fernandes, C.; Tavares, N.; Rey, C.; Sarmento, C. The role of postoperative prognostic nutritional index as a prognostic factor and its association to systemic inflammatory response markers in stage III colon cancer. Ann. Oncol. 2020, 31, S201. [Google Scholar] [CrossRef]
- Treasure, M.E.; Thomas, A.; Ganocy, S.; Hong, A.; Krishnamurthi, S.S.; Bajor, D.L.; Berger, N.A.; Meropol, N.J. A pilot study to determine the feasibility of a customized low glycemic load diet in patients with stage I-III colorectal cancer. J. Clin. Oncol. 2020, 38, 4643. [Google Scholar] [CrossRef]
- da Silva Dias, D.; Fortuna, A.; Alves, L.; Luz, P.; Madureira, T.; Gosalbez, B. Nutritional intervention impact on body mass index and toxicities related to 1st-line metastatic colorectal cancer treatment with targeted therapy. Ann. Oncol. 2020, 31, S194. [Google Scholar] [CrossRef]
- Gallois, C.; Bourillon, C.; Auclin, E.; Artru, P.; Lievre, A.; Lecomte, T.; Locher, C.; Marthey, L.; Faroux, R.; Pernot, S.; et al. Skeletal muscle loss under chemotherapy and its association with survival and systemic treatment toxicity in metastatic colorectal cancer: An AGEO prospective multicenter study. J. Clin. Oncol. 2020, 38, 4025. [Google Scholar] [CrossRef]
- Goncalves, J.; Gil, J.; Forones, N. SIBO and lactose intolerance in patients receiving chemotherapy treatment for colorectal or gastric cancer. Ann. Oncol. 2020, 31, S207. [Google Scholar] [CrossRef]
- Aizawa, M.; Yabusaki, H.; Matsuki, A.; Bamba, T.; Nakagawa, S. The impact of surgery induced immune-nutritional change on the outgrowth of micrometastasis after potentially curative resection for gastric cancer. J. Clin. Oncol. 2020, 38, e16581. [Google Scholar] [CrossRef]
- Cipriano, E.; Estevinho, H.; Magalhaes, H. Prognostic factors in metastatic gastric cancer patients. Ann. Oncol. 2020, 31, S146. [Google Scholar] [CrossRef]
- Squires, M.H.; Benbow, J.H.; Trufan, S.J.; Mann, D.; Burchins, E.M.; Byrne, M.M.; Hill, J.; Gower, N.L.; Salo, J.C. Weight loss after minimally-invasive esophagectomy for esophageal cancer. J. Clin. Oncol. 2020, 38, e16565. [Google Scholar] [CrossRef]
- Soriano, J.; Hueniken, K.; Bajwa, J.K.; Dong, G.; Wang, W.; Soberano, T.; Taylor, K.; Brown, M.C.; Chen, E.X.; Knox, J.J.; et al. Impact of body measurements (BM) on overall survival (OS) and quality of life (QoL) in real-world patients (pts) with metastatic esophageal cancer. J. Clin. Oncol. 2020, 38, 4544. [Google Scholar] [CrossRef]
- Trestini, I.; Paiella, S.; Sandini, M.; Hank, T.; Pollini, T.; Sperduti, I.; Melisi, D.; Auriemma, A.; Soldà, C.; Tregnago, D.; et al. Sarcopenia and sarcopenic obesity in pancreatic ductal adenocarcinoma (PDAC) patients undergoing surgery after neoadjuvant therapy (NAT): Clinical implications. J. Clin. Oncol. 2020, 38, e16769. [Google Scholar] [CrossRef]
- Appleyard, J.; Kamposorias, K.; Papaxoinis, G.; Collinson, F.; Ahmad, U.; Wright, F.; Damyanova, I.; Razzaq, M.; Anthoney, A. Markers of tumour inflammation are prognostic for overall survival in patients with advanced pancreatic ductal adenocarcinoma receiving FOLFIRINOX chemotherapy. Ann. Oncol. 2020, 31, S131. [Google Scholar] [CrossRef]
- Atkins, K.M.; Gong, J.; Tighiouart, M.; Klempner, S.J.; Tuli, R.; Placencio-Hickok, V.; Hendifar, A.E. A phase I study of nanoliposomal irinotecan and 5-fluorouracil/folinic acid in combination with interleukin-1-alpha antagonist for advanced pancreatic cancer patients with cachexia (OnFX). J. Clin. Oncol. 2020, 38, TPS780. [Google Scholar] [CrossRef]
- Muscaritoli, M.; Arends, J.; Aapro, M. From guidelines to clinical practice: A roadmap for oncologists for nutrition therapy for cancer patients. Ther Adv. Med. Oncol. 2019, 11, 1758835919880084. [Google Scholar] [CrossRef] [PubMed]
- Muscaritoli, M.; Lucia, S.; Farcomeni, A.; Lorusso, V.; Saracino, V.; Barone, C.; Plastino, F.; Gori, S.; Magarotto, R.; Carteni, G.; et al. Prevalence of malnutrition in patients at first medical oncology visit: The PreMiO study. Oncotarget 2017, 8, 79884–79896. [Google Scholar] [CrossRef] [PubMed]
- Hebuterne, X.; Lemarie, E.; Michallet, M.; de Montreuil, C.B.; Schneider, S.M.; Goldwasser, F. Prevalence of malnutrition and current use of nutrition support in patients with cancer. J. Parenter. Enteral. Nutr. 2014, 38, 196–204. [Google Scholar] [CrossRef] [PubMed]
- Derstine, B.A.; Holcombe, S.A.; Ross, B.E.; Wang, N.C.; Su, G.L.; Wang, S.C. Skeletal muscle cutof values for sarcopenia diagnosis using T10 to L5 measurements in a healthy US population. Sci. Rep. 2018. [Google Scholar] [CrossRef] [PubMed]
- Facciorusso, A.; Antonino, M.; Muscatiello, N. Sarcopenia represents a negative prognostic factor in pancreatic cancer patients undergoing EUS celiac plexus neurolysis. Endosc Ultrasound 2020, 9, 238–244. [Google Scholar] [CrossRef] [PubMed]
- Uemura, S.; Iwashita, T.; Ichikawa, H.; Iwasa, Y. The impact of sarcopenia and decrease in skeletal muscle mass in patients with advanced pancreatic cancer during FOLFIRINOX therapy. Br. J. Nutr. 2020. [Google Scholar] [CrossRef]
- Arends, J.; Bachmann, P.; Baracos, V.; Barthelemy, N.; Bertz, H.; Bozzetti, F.; Fearon, K.; Hutterer, E.; Isenring, E.; Kaasa, S.; et al. ESPEN guidelines on nutrition in cancer patients. Clin. Nutr. 2017, 36, 11–48. [Google Scholar] [CrossRef]
Screening Instruments | Main Measures |
---|---|
Malnutrition Screening Tool | Unintentional weight loss, appetite |
Nutritional Risk Screening 2002 | Weight loss, BMI, food intake |
Malnutrition Universal Screening Tool | BMI, weight changes |
Screening Instruments | Main Measures |
---|---|
Subjective Global Assessment (SGA) | Weight loss, food intake, GI symptoms, functional capacity |
Patient-Generated SGA (PG-SGA) | Weight loss, food intake, GI symptoms, functional capacity |
Revised Mini Nutritional Assessment Short Form Prognostic Nutritional Index (PNI) | BMI or calf circumference, weight loss, appetite Serum albumin, blood lymphocyte count |
Article Reference | Geographical Origin | Index | Results |
---|---|---|---|
Colorectal Cancer | |||
Costa et al., 2020 [9] | Portugal | PNI | Low PNI: worst results in stage III CRC patients submitted to curative surgery and adjuvant chemotherapy (CT). |
Treasure et al., 2020 [10] | USA | GL | CRC patients with a low glycemic index diet:
|
da Silva Dias et al., 2020 [11] | Portugal | BMI | Low BMI at diagnosis:
|
Gallois et al., 2020 [12] | France | SMI | Decrease in SMI > 14% during first 2 months of treatment was associated with decreased OS. |
Goncalves et al., 2020 [13] | Brazil | SIBO and lactose intolerance | Diarrhea caused by CT treatment for CRC or gastric cancer was independent of the presence of SIBO or lactose intolerance. |
Gastric Cancer | |||
Aizawa et al., 2020 [14] | Japan | PNI | Low PNI related to recurrence after GC resection in the locally advanced disease. |
Cipriano et al., 2020 [15] | Portugal | NLR |
|
Esophageal Cancer | |||
Squires et al., 2020 [16] | USA | Weight loss |
|
Soriano et al., 2020 [17] | Canada | SMI, VAT, SAT |
|
Pancreatic Cancer | |||
Trestini et al., 2020 [18] | Italy | BC |
|
Appleyard et al., 2020 [19] | United Kingdom | PNI | PNI associated with OS. |
Atkins et al.; 2020 [20] | USA | BC | Bermekimab, nano-liposomal irinotecan and 5-fluorouracil in refractory pancreatic cancer patients with cachexia:
|
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Mascaretti, F.; Evangelista, J. Nutritional Assessment in Gastrointestinal Tumors: News from the 2020 ASCO and ESMO World GI Meetings. Gastrointest. Disord. 2020, 2, 310-317. https://doi.org/10.3390/gidisord2030028
Mascaretti F, Evangelista J. Nutritional Assessment in Gastrointestinal Tumors: News from the 2020 ASCO and ESMO World GI Meetings. Gastrointestinal Disorders. 2020; 2(3):310-317. https://doi.org/10.3390/gidisord2030028
Chicago/Turabian StyleMascaretti, Federica, and Jessica Evangelista. 2020. "Nutritional Assessment in Gastrointestinal Tumors: News from the 2020 ASCO and ESMO World GI Meetings" Gastrointestinal Disorders 2, no. 3: 310-317. https://doi.org/10.3390/gidisord2030028
APA StyleMascaretti, F., & Evangelista, J. (2020). Nutritional Assessment in Gastrointestinal Tumors: News from the 2020 ASCO and ESMO World GI Meetings. Gastrointestinal Disorders, 2(3), 310-317. https://doi.org/10.3390/gidisord2030028